- Home
- SAVA vs LVO Comparison
SAVA vs LVO Comparison
Compare SAVA & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- LVO
- Stock Information
- Founded
- SAVA 1998
- LVO 2009
- Country
- SAVA United States
- LVO United States
- Employees
- SAVA N/A
- LVO N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- LVO Restaurants
- Sector
- SAVA Health Care
- LVO Consumer Discretionary
- Exchange
- SAVA Nasdaq
- LVO Nasdaq
- Market Cap
- SAVA 70.5M
- LVO 82.1M
- IPO Year
- SAVA N/A
- LVO N/A
- Fundamental
- Price
- SAVA $2.35
- LVO $0.73
- Analyst Decision
- SAVA Buy
- LVO Strong Buy
- Analyst Count
- SAVA 2
- LVO 1
- Target Price
- SAVA $54.50
- LVO $1.50
- AVG Volume (30 Days)
- SAVA 1.2M
- LVO 1.2M
- Earning Date
- SAVA 08-07-2025
- LVO 08-12-2025
- Dividend Yield
- SAVA N/A
- LVO N/A
- EPS Growth
- SAVA N/A
- LVO N/A
- EPS
- SAVA N/A
- LVO N/A
- Revenue
- SAVA N/A
- LVO $114,405,000.00
- Revenue This Year
- SAVA N/A
- LVO N/A
- Revenue Next Year
- SAVA N/A
- LVO $19.08
- P/E Ratio
- SAVA N/A
- LVO N/A
- Revenue Growth
- SAVA N/A
- LVO N/A
- 52 Week Low
- SAVA $1.15
- LVO $0.55
- 52 Week High
- SAVA $42.20
- LVO $1.82
- Technical
- Relative Strength Index (RSI)
- SAVA 56.89
- LVO 46.34
- Support Level
- SAVA $2.11
- LVO $0.64
- Resistance Level
- SAVA $2.72
- LVO $0.75
- Average True Range (ATR)
- SAVA 0.16
- LVO 0.06
- MACD
- SAVA 0.04
- LVO -0.01
- Stochastic Oscillator
- SAVA 52.56
- LVO 39.09
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.